Biological material, preparation method and application thereof, and mask
Through the cross-linking reaction of tanninic acid self-crosslinking microspheres with amine compounds and the combination of arginine, the problem of insufficient stability and antibacterial performance of natural polysaccharide materials in the prior art was solved, and a high anti-inflammatory and antibacterial activity was prepared. Biomaterials, suitable for a variety of medical and skin care products.
Patent Information
- Application Number
- CN202411428373.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-14
- Publication Date
- 2024-11-19
- Estimated Expiration
- 2044-10-14
AI Technical Summary
The existing method for compositeing natural polysaccharides and amine compounds has problems with esterification reaction condensant and oxidant residues and toxicity, which limits its application in biomedical materials.
A new type of novel prepared by cross-linking reaction of tanninic acid self-crosslinking microspheres with amine compounds and covalently and hydrogen-bonded interactions with natural polysaccharide macromolecules, combining arginine to improve anti-inflammatory and antibacterial activities, and a new type of protein was prepared by combining with arginine. biomaterials.
It has achieved the improvement of the stability and safety of biological materials, has good anti-inflammatory and antibacterial activities, and is suitable for wound dressings, medical filling materials and skin care products, with good application prospects.
Smart Images

Figure CN118976134A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of biomedical materials, and in particular to a biomaterial, a preparation method and application thereof, and a facial mask. Background Art
[0002] Natural polysaccharide compounds such as hyaluronic acid and chondroitin sulfate have been widely used in the biomedical field due to their excellent biocompatibility and bioactivity, such as wound dressings, medical filling materials, and skin care products. How to further stabilize the bioactivity of natural polysaccharides and improve their anti-degradation performance has always been a hot topic of widespread concern. Amine compounds, especially amine-containing polymers, have been widely used in the field of antibacterial materials due to their good antibacterial properties. At the same time, it has been proven to be an effective way to improve the antibacterial properties and stability of natural polysaccharide materials by combining natural polysaccharides with amine compounds. In recent years, the composite strategies of natural polysaccharides and amine compounds mainly include the esterification reaction of amine groups with polysaccharide carboxyl groups and the condensation reaction of aldehyde groups and amine groups after polysaccharide oxidation. However, the above methods still have problems such as residual esterification reaction condensation agents and reaction products, the use of strong oxidizing agents to cause polysaccharide chain breakage, and oxidant toxicity, which limits their further application. Therefore, it is of great significance to develop a new strategy for stabilizing natural polysaccharides.
[0003] In view of this, the present invention is proposed. Summary of the invention
[0004] The first purpose of the present invention is to provide a method for preparing a biomaterial, by cross-linking tannic acid self-cross-linking microspheres with amine compounds and interacting with polyhydroxy natural macromolecules through covalent and hydrogen bonds, thereby further introducing anti-inflammatory and antibacterial activities on the basis of stable natural polysaccharide macromolecules.
[0005] The second object of the present invention is to provide a biomaterial.
[0006] The third object of the present invention is to provide the use of the above-mentioned biomaterial in the preparation of wound dressings, medical filling materials or skin care products.
[0007] A fourth object of the present invention is to provide a facial mask.
[0008] In order to achieve the above objectives, the following technical solutions are adopted: In a first aspect, the present invention provides a method for preparing a biomaterial, comprising the following steps: The biomaterial is prepared by mixing natural polysaccharide macromolecules or their sodium salt, tannic acid self-crosslinked microspheres and water, then adding an amine compound for crosslinking reaction, and then mixing with arginine after the crosslinking reaction is completed; Calculated by weight, the raw materials of the biomaterial include 1-10 parts of natural polysaccharide macromolecules, 0.01-10 parts of tannic acid self-crosslinked microspheres, 200 parts of water, 0.06-0.08 parts of amine compounds and 0.01-0.1 parts of arginine.
[0009] As a further technical solution, the natural polysaccharide macromolecules include hyaluronic acid, alginate, chitosan or chondroitin sulfate.
[0010] As a further technical solution, the particle size of the tannic acid self-crosslinking microspheres is 200-400 nanometers.
[0011] As a further technical solution, the method for preparing the tannic acid self-crosslinked microspheres comprises: adding an oxidant to a tannic acid solution to carry out a self-crosslinking reaction, and then obtaining the tannic acid self-crosslinked microspheres after separation.
[0012] As a further technical solution, the amine compound includes lysine, polylysine or polyimide; The molecular weight of the polylysine and polyimide is 1000-10000Da.
[0013] As a further technical solution, the temperature of the cross-linking reaction is 5-40°C; The cross-linking reaction time is 1-24h.
[0014] In a second aspect, the present invention provides a biomaterial prepared by the above-mentioned preparation method.
[0015] In a third aspect, the present invention provides the use of the above-mentioned biomaterial in the preparation of wound dressings, medical filling materials or skin care products.
[0016] In a fourth aspect, the present invention provides a facial mask, comprising liquid A and liquid B; The liquid A comprises the above-mentioned biological material and whitening and skin care ingredients; The B solution is an aqueous solution of calcium salt.
[0017] As a further technical solution, the method for preparing the facial mask comprises: applying liquid A on the skin surface, then spraying liquid B, and preparing the facial mask after film formation.
[0018] Compared with the prior art, the present invention has the following beneficial effects: The method for preparing the biomaterial provided by the present invention is simple and efficient. The prepared biomaterial has good anti-inflammatory and antibacterial activity, good stability and high safety. It can be used to prepare wound dressings, medical filling materials or skin care products, and has good application prospects. BRIEF DESCRIPTION OF THE DRAWINGS
[0019] In order to more clearly illustrate the specific implementation methods of the present invention or the technical solutions in the prior art, the drawings required for use in the specific implementation methods or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are some implementation methods of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0020] Figure 1 The antibacterial results of the blank control, Example 1 and Comparative Example 3 are shown; Figure 2 The biosafety results of Example 1 (left) and Comparative Example 3 (right). DETAILED DESCRIPTION
[0021] The embodiments of the present invention will be described in detail below in conjunction with the embodiments and examples, but it will be appreciated by those skilled in the art that the following embodiments and examples are only used to illustrate the present invention and should not be considered as limiting the scope of the present invention. Based on the embodiments in the present invention, all other embodiments obtained by those of ordinary skill in the art without making creative work are within the scope of protection of the present invention. If specific conditions are not specified, proceed according to normal conditions or conditions recommended by the manufacturer. If the manufacturer is not specified for the reagents or instruments used, they are all conventional products that can be purchased commercially.
[0022] In a first aspect, the present invention provides a method for preparing a biomaterial, comprising the following steps: The biomaterial is prepared by mixing natural polysaccharide macromolecules or their sodium salt, tannic acid self-crosslinked microspheres and water, then adding an amine compound for crosslinking reaction, and then mixing with arginine after the crosslinking reaction is completed; The raw materials of the biomaterial include natural polysaccharide macromolecules, tannic acid self-crosslinked microspheres, water, amine compounds and arginine. Among them, by mass fraction, the mass fraction of natural polysaccharide macromolecules can be, for example, but not limited to 1 part, 2 parts, 4 parts, 6 parts, 8 parts or 10 parts; the mass fraction of tannic acid self-crosslinked microspheres can be, for example, but not limited to 0.01 parts, 0.05 parts, 0.1 parts, 0.5 parts, 1 parts, 5 parts or 10 parts; the mass fraction of water is 200 parts; the mass fraction of amine compounds can be, for example, but not limited to 0.06 parts, 0.07 parts or 0.08 parts; the mass fraction of arginine can be, for example, but not limited to 0.01 parts, 0.05 parts or 0.1 parts.
[0023] Arginine is added after the cross-linking reaction is completed. The inventors have found that the addition of arginine can react with the aldehyde group of the cross-linked product to improve the safety of the biomaterial; at the same time, the addition of arginine can also improve the stability of the biomaterial and improve the repair effect of the biomaterial.
[0024] The method for preparing the biomaterial provided by the present invention is simple and efficient. The prepared biomaterial has good anti-inflammatory and antibacterial activity, good stability and high safety. It can be used to prepare wound dressings, medical filling materials or skin care products, and has good application prospects.
[0025] In some optional embodiments, the natural polysaccharide macromolecules include but are not limited to hyaluronic acid, alginate, chitosan or chondroitin sulfate, or other natural polysaccharide macromolecules well known to those skilled in the art.
[0026] In some optional embodiments, the particle size of the tannic acid self-crosslinked microspheres is 200-400 nanometers.
[0027] In some optional embodiments, the method for preparing the tannic acid self-crosslinked microspheres comprises: adding an oxidant to a tannic acid solution to carry out a self-crosslinking reaction, and then obtaining the tannic acid self-crosslinked microspheres after separation.
[0028] In some optional embodiments, the oxidizing agent comprises sodium periodate.
[0029] In some optional embodiments, the preparation method of the tannic acid self-crosslinked microspheres is as follows: 45 mg of tannic acid is dissolved in 10 mL of pure water, 200 µL of sodium periodate solution (20 mM) is added to the solution after stirring and mixing, and the mixture is reacted overnight at room temperature in the dark. After dialysis with deionized water (MCWO=2000) and freeze-drying, the tannic acid self-crosslinked microspheres are obtained.
[0030] In some optional embodiments, the amine compound includes but is not limited to lysine, polylysine or polyimide; The molecular weights of the polylysine and polyimide are in the range of 1000-10000 Da.
[0031] The amine compounds within the above molecular weight range can meet both the requirements of biological activity and water solubility.
[0032] In some optional embodiments, the temperature of the cross-linking reaction may be, for example, but not limited to, 5°C, 10°C, 20°C, 30°C or 40°C; The cross-linking reaction time may be, for example, but not limited to, 1 h, 6 h, 12 h, 18 h or 24 h.
[0033] In a second aspect, the present invention provides a biomaterial prepared by the above-mentioned preparation method.
[0034] The prepared biomaterial has good anti-inflammatory and antibacterial activity, good stability and high safety. It can be used to prepare wound dressings, medical filling materials or skin care products and has good application prospects.
[0035] In a third aspect, the present invention provides the use of the above-mentioned biomaterial in the preparation of wound dressings, medical filling materials or skin care products.
[0036] In a fourth aspect, the present invention provides a facial mask, comprising liquid A and liquid B; The liquid A comprises the above-mentioned biological material and whitening and skin care ingredients; The B solution is an aqueous solution of calcium salt.
[0037] In some optional embodiments, the whitening skin care ingredients include salicylic acid, vitamin C, asiatica glycoside, arbutin, kojic acid, niacinamide or vitamin B derivatives; In some optional embodiments, the amount of the whitening skin care ingredient is 0.5-3 g / mL.
[0038] In some optional embodiments, the concentration of calcium salt in the solution B is 0.5-1.5 g / mL.
[0039] In some optional embodiments, the method for preparing the facial mask comprises: applying liquid A on the skin surface, and then spraying liquid B, to form a film to obtain the facial mask.
[0040] The mask can effectively avoid the problems of existing masks such as incomplete facial coverage, dead corners, and mismatch between mask size and face shape.
[0041] The present invention is further described below by means of specific examples and comparative examples. However, it should be understood that these examples are only used for more detailed description and should not be construed as limiting the present invention in any form.
[0042] Unless otherwise specified, in the following examples and comparative example 1, the preparation method of tannic acid self-crosslinked microspheres is as follows: 45 mg of tannic acid is dissolved in 10 mL of pure water, and after stirring and mixing, 200 µL of sodium periodate solution (20 mM) is added to the solution, and the mixture is reacted overnight at room temperature in the dark. After dialysis with deionized water (MCWO=2000) and freeze-drying, tannic acid self-crosslinked microspheres are obtained. The particle size of the tannic acid self-crosslinked microspheres is 200-400 nanometers.
[0043] Example 1 (1) Under room temperature, dissolve 5 g of sodium hyaluronate in 200 mL of deionized water and stir to obtain an aqueous solution of sodium hyaluronate; (2) Add 0.08 g of tannic acid self-crosslinked microspheres to the above sodium hyaluronate solution, stir for 1 hour, then add 0.08 g of polylysine (molecular weight 3000), continue stirring for 24 hours, then add 0.02 g of arginine, stir and mix to obtain the target biomaterial.
[0044] Example 2 (1) At room temperature, dissolve 6 g of sodium hyaluronate in 200 mL of deionized water and stir to obtain an aqueous solution of sodium hyaluronate; (2) Add 0.06 g of tannic acid self-crosslinked microspheres to the above sodium hyaluronate solution, stir for 10 hours, then add 0.06 g of polylysine (molecular weight 3000), continue stirring for 24 hours, then add 0.01 g of arginine, stir and mix to obtain the target biomaterial.
[0045] Example 3 (1) At room temperature, dissolve 6 g of sodium hyaluronate in 200 mL of deionized water and stir to obtain an aqueous solution of sodium hyaluronate; (2) 0.1 g of tannic acid self-crosslinked microspheres were added to the above sodium hyaluronate solution. After reacting for 1 hour, 0.06 g of polylysine (molecular weight 5000) was further added. After stirring for 10 hours, 0.04 g of arginine was added. After stirring and mixing, the target biomaterial was prepared.
[0046] Example 4 (1) At room temperature, dissolve 6 g of sodium hyaluronate in 200 mL of deionized water and stir to obtain an aqueous solution of sodium hyaluronate; (2) 0.1 g of tannic acid self-crosslinked microspheres were added to the above sodium hyaluronate solution. After reacting for 1 hour, 0.06 g of polyimide (molecular weight 2000) was further added. After stirring for 10 hours, 0.04 g of arginine was added. After stirring and mixing, the target biomaterial was prepared.
[0047] Example 5 (1) Dissolve 1 g of chondroitin sulfate in 200 mL of deionized water at room temperature and stir to obtain an aqueous solution of chondroitin sulfate; (2) To the chondroitin sulfate solution prepared in (1) above, 0.08 g of tannic acid self-crosslinked microspheres were added, and after stirring for 10 hours, 0.08 g of polylysine (molecular weight 3000) was further added. After stirring for 24 hours, 0.02 g of arginine was added, and the target biomaterial was prepared after stirring and mixing.
[0048] Example 6 (1) Dissolve 1 g of acidified chitosan in 200 mL of deionized water at room temperature and stir to obtain an aqueous solution of sodium hyaluronate; (2) 0.08 g of tannic acid self-crosslinked microspheres were added to the sodium hyaluronate solution prepared in (1) above. After stirring for 1 hour, 0.08 g of polylysine (molecular weight 3000) was further added. After further stirring for 10 hours, 0.02 g of arginine was added. After stirring and mixing, the target biomaterial was prepared.
[0049] Example 7 (1) Under room temperature, dissolve 10 g of sodium hyaluronate in 200 mL of deionized water and stir to obtain an aqueous solution of sodium hyaluronate; (2) Add 0.01 g of tannic acid self-crosslinked microspheres to the above sodium hyaluronate solution, stir for 1 hour, then add 0.07 g of polylysine (molecular weight 1000), continue stirring for 24 hours, then add 0.02 g of arginine, stir and mix to obtain the target biomaterial.
[0050] Example 8 (1) Under room temperature, dissolve 10 g of sodium hyaluronate in 200 mL of deionized water and stir to obtain an aqueous solution of sodium hyaluronate; (2) Add 10 g of tannic acid self-crosslinked microspheres to the above sodium hyaluronate solution, stir for 1 hour, then add 0.07 g of polylysine (molecular weight 10,000), continue stirring for 24 hours, then add 0.1 g of arginine, stir and mix to obtain the target biomaterial.
[0051] Comparative Example 1 The difference from Example 1 is that the tannic acid self-crosslinking microspheres are replaced by an equal amount of tannic acid.
[0052] Comparative Example 2 The difference from Example 1 is that the tannic acid self-crosslinked microspheres are replaced by an equal amount of tea polyphenols.
[0053] Comparative Example 3 The difference from Example 1 is that arginine was not added.
[0054] Test Example 1 The biomaterials provided in the examples and comparative examples were tested for stability (the prepared materials were placed for 7 days to observe whether precipitation was produced) and antibacterial activity (the number of colonies was counted by plate antibacterial experiment: Staphylococcus aureus was diluted with PBS to 10 / ml. 6 Then, 180 μl of bacterial solution and 20 μl of sample were respectively pipetted into the well plate, incubated in a 37°C constant temperature incubator for 6-8 h, and 50 μl was taken for plate coating. After incubation in a 37°C constant temperature incubator for 12 h, the number of colonies was observed. The results are shown in Table 1 and Figure 1 shown.
[0055] Table 1 Properties and antibacterial properties of target materials in different formulations .
[0056] It can be seen that the materials of Examples 1-8 of the present invention have better stability and higher antibacterial properties than those of Comparative Examples 1-2. The reason why Comparative Examples 1-2 have poor stability may be due to local excessive cross-linking.
[0057] Test Example 2 The materials provided in Example 1 and Comparative Example 3 were subjected to a biosafety experiment, and the experimental steps were as follows: The cytotoxicity of the material was evaluated by the CCK-8 method. After freeze-drying and sterilization, the samples were prepared with complete culture medium to the sample group with the initial concentration, and the complete culture medium was set as the blank control group. Mouse fibroblasts (L929) were seeded in a 96-well plate at a density of 10,000 cells per well, and 200 microliters of culture medium were added to each well. After 24 hours of culture, the culture medium was replaced with 200 microliters of the sample group or blank group, and 6 parallel samples were set up for each group. After incubation for 24 hours and 48 hours, respectively, the original culture medium was discarded and replaced with 100 microliters of CCK-8 solution (10%, v / v). After continuing to incubate for 1 hour, the absorbance value of each well at 450 nm was measured with an enzyme reader and the cytotoxicity value was calculated. The results are shown in Figure 2 As shown. It can be seen that the material of Example 1 of the present invention has higher safety than that of Comparative Example 3. This may be because arginine can react with the aldehyde group in the material, thereby improving the safety of the material.
[0058] Example 9 A facial mask, comprising liquid A and liquid B; The liquid A comprises the biological material provided in Example 1 and a whitening and skin care component (salicylic acid, content of 0.1%); The B solution is an aqueous solution of calcium chloride with a concentration of 1%.
[0059] Usage: Apply liquid A on the skin surface, then spray liquid B, and after film formation, the facial mask is prepared.
[0060] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or replace some or all of the technical features therein by equivalents. However, these modifications or replacements do not cause the essence of the corresponding technical solutions to deviate from the scope of the technical solutions of the embodiments of the present invention.
Claims
1. A method for preparing a biomaterial, characterized in that: The following steps are involved: The biomaterial is prepared by mixing natural polysaccharide macromolecules or their sodium salt, tannic acid self-crosslinked microspheres and water, then adding an amine compound for crosslinking reaction, and then mixing with arginine after the crosslinking reaction is completed; Calculated by weight, the raw materials of the biomaterial include 1-10 parts of natural polysaccharide macromolecules, 0.01-10 parts of tannic acid self-crosslinked microspheres, 200 parts of water, 0.06-0.08 parts of amine compounds and 0.01-0.1 parts of arginine.
2. The preparation method according to claim 1, characterized in that: The natural polysaccharide macromolecules include hyaluronic acid, alginic acid, chitosan or chondroitin sulfate.
3. The preparation method according to claim 1, characterized in that: The particle size of the tannic acid self-crosslinked microspheres is 200-400 nanometers.
4. The preparation method according to claim 1, characterized in that: The preparation method of the tannic acid self-crosslinking microspheres comprises: adding an oxidant to a tannic acid solution to carry out a self-crosslinking reaction, and then obtaining the tannic acid self-crosslinking microspheres after separation.
5. The preparation method according to claim 1, characterized in that: The amine compound includes lysine, polylysine or polyimide; The molecular weight of the polylysine and polyimide is 1000-10000Da.
6. The preparation method according to claim 1, characterized in that: The temperature of the cross-linking reaction is 5-40°C; The cross-linking reaction time is 1-24h.
7. A biomaterial, characterized in that: The preparation method is described in any one of claims 1 to 6.
8. Use of the biomaterial according to claim 7 in the preparation of wound dressings, medical filling materials or skin care products.
9. A facial mask, characterized in that: Including A liquid and B liquid; The liquid A comprises the biological material according to claim 7 and a whitening and skin care component; The B solution is an aqueous solution of calcium salt.
10. The facial mask according to claim 9, characterized in that: The method for preparing the facial mask comprises: applying liquid A on the skin surface, then spraying liquid B, and forming a film to obtain the facial mask.
Citation Information
Patent Citations
Self-crosslinking injection cosmetic filler and preparation method
CN108465124A
Tannic acid cross-linked chitosan / gelatin liquid-absorbing hemostatic antibacterial sponge and preparation method thereof
CN112646228A
Treatment method of cross-linked biological tissue
CN113786515A
Tannic acid modified gelatin-based hydrogel wound dressing and preparation method thereof
CN115487346A
Polylysine-based antibacterial medical bone tissue adhesive as well as preparation method and application thereof
CN116350833A
